GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Joincare Pharmaceutical Group Industry Co Ltd (SHSE:600380) » Definitions » Asset Turnover

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Asset Turnover : 0.12 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Joincare Pharmaceutical Group Industry Co Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Joincare Pharmaceutical Group Industry Co's Revenue for the three months ended in Mar. 2024 was ¥4,340 Mil. Joincare Pharmaceutical Group Industry Co's Total Assets for the quarter that ended in Mar. 2024 was ¥36,410 Mil. Therefore, Joincare Pharmaceutical Group Industry Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.12.

Asset Turnover is linked to ROE % through Du Pont Formula. Joincare Pharmaceutical Group Industry Co's annualized ROE % for the quarter that ended in Mar. 2024 was 12.57%. It is also linked to ROA % through Du Pont Formula. Joincare Pharmaceutical Group Industry Co's annualized ROA % for the quarter that ended in Mar. 2024 was 4.83%.


Joincare Pharmaceutical Group Industry Co Asset Turnover Historical Data

The historical data trend for Joincare Pharmaceutical Group Industry Co's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joincare Pharmaceutical Group Industry Co Asset Turnover Chart

Joincare Pharmaceutical Group Industry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.51 0.54 0.51 0.46

Joincare Pharmaceutical Group Industry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.12 0.11 0.11 0.12

Competitive Comparison of Joincare Pharmaceutical Group Industry Co's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Joincare Pharmaceutical Group Industry Co's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Joincare Pharmaceutical Group Industry Co's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Joincare Pharmaceutical Group Industry Co's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Joincare Pharmaceutical Group Industry Co's Asset Turnover falls into.



Joincare Pharmaceutical Group Industry Co Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Joincare Pharmaceutical Group Industry Co's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=16646.35/( (35735.43+36358.126)/ 2 )
=16646.35/36046.778
=0.46

Joincare Pharmaceutical Group Industry Co's Asset Turnover for the quarter that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=4339.814/( (36358.126+36462.147)/ 2 )
=4339.814/36410.1365
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Joincare Pharmaceutical Group Industry Co  (SHSE:600380) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Joincare Pharmaceutical Group Industry Co's annulized ROE % for the quarter that ended in Mar. 2024 is

ROE %**(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=1759.192/13995.386
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(1759.192 / 17359.256)*(17359.256 / 36410.1365)*(36410.1365/ 13995.386)
=Net Margin %*Asset Turnover*Equity Multiplier
=10.13 %*0.4768*2.6016
=ROA %*Equity Multiplier
=4.83 %*2.6016
=12.57 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Joincare Pharmaceutical Group Industry Co's annulized ROA % for the quarter that ended in Mar. 2024 is

ROA %(Q: Mar. 2024 )
=Net Income/Total Assets
=1759.192/36410.1365
=(Net Income / Revenue)*(Revenue / Total Assets)
=(1759.192 / 17359.256)*(17359.256 / 36410.1365)
=Net Margin %*Asset Turnover
=10.13 %*0.4768
=4.83 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Joincare Pharmaceutical Group Industry Co Asset Turnover Related Terms

Thank you for viewing the detailed overview of Joincare Pharmaceutical Group Industry Co's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Joincare Pharmaceutical Group Industry Co (SHSE:600380) Business Description

Traded in Other Exchanges
N/A
Address
No. 17 Langshan Road, Joincare Pharmaceutical Group Building, Nanshan New and High-Tech Industrial Development (, Shenzhen, Guangdong, CHN, 518057
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
Executives
Yu Xiong Directors, senior managers
Zhao Feng Guang senior management
Qiu Qing Feng Directors, senior managers
Tang Ling Zhi senior management
Lin Nan Qi Directors, senior managers
Cao Ping Wei Director
Feng Yan Fang Director
Zhong Shan senior management
Yang Dong Yun senior management
Peng Jin Hua Supervisors
Xie You Guo Supervisors
Guo Xiao Yun Supervisors
Su Qing Wen senior management

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Headlines

No Headlines